1) Ustekinumab (Genetical Recombination) 45 mg 1syringe 147 syringes 2) Lenalidomide Hydrate 5 mg 40 capsules/case 173 cases 3) Infliximab (Genetical recombination) 100 mg 1 vial 567 vials 4) Daratumumab (Genetical Recombination) 20 mg 1 vial 221 vials

This tender with title 1) Ustekinumab (Genetical Recombination) 45 mg 1syringe 147 syringes 2) Lenalidomide Hydrate 5 mg 40 capsules/case 173 cases 3) Infliximab (Genetical recombination) 100 mg 1 vial 567 vials 4) Daratumumab (Genetical Recombination) 20 mg 1 vial 221 vials has been published on Bidding Source portal dated 02 Aug 2021 for the country of Japan. It has been categorized on Syringes & Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.